Effect of TTYH3 on cholangiocarcinoma invasion, metastasis and lymph node metastasis through Wnt/β-catenin pathway.

Authors

null

Yuwei Xie

Affiliated Hospital of Qingdao University, Qingdao, China

Yuwei Xie , Shengze Wu , Fangqian Du , Ruiqian Gao , Tingting Wu , Chen Jin , Jingyu Cao , Chengzhan Zhu

Organizations

Affiliated Hospital of Qingdao University, Qingdao, China, the Affiliated Hospital of Qingdao University, Qingdao, China, The Affiliated Hospital of Qingdao University, Qingdao, China, Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China

Research Funding

The study was supported by Taishan Scholars Program of Shandong Province
Natural Science Foundation of Shandong Province, Shandong Higher Education Young Science and Technology Support Program

Background: Cholangiocarcinoma is a malignant tumor originating from the bile duct epithelium. Metastasis is an important factor affecting the prognosis of cholangiocarcinoma. To explore the role and mechanism of calcium-activated chloride channel protein Tweety homolog 3 (TTYH3) in cholangiocarcinoma metastasis. Methods: TTYH3 was overexpressed and knocked down in cholangiocarcinoma cells, and in vitro experiments were performed to clarify the biological function of TTYH3 in cholangiocarcinoma. Experiments on xenograft tumor mice model have shown that TTYH3 promotes tumorigenesis of cholangiocarcinoma cells. Analysis of the relationship between TTYH3 expression and patient prognosis and lymph node metastasis in cholangiocarcinoma tissue specimens. Exosomes were extracted from bile of patients with cholangiocarcinoma and bile duct stones, and the expression of TTYH3 in exosomes was compared. TTYH3 overexpressed exosomes were used to treat endothelial cells, and their function and mechanism in promoting lymphangiogenesis were analyzed. Results: In vitro experiments confirmed that TTYH3 promoted the migration and invasion of cholangiocarcinoma cell line QBC939. In vivo experiments confirmed that TTYH3 promotes the tumorigenesis of cholangiocarcinoma cells. TTYH3 promotes epithelial-to-mesenchymal transition of cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway. TTYH3 promotes cholangiocarcinoma cell self-expression through positive feedback. TTYH3 is highly expressed in cholangiocarcinoma tissues. Patients with high TTYH3 expression have poor prognosis and a high incidence of lymph node metastasis. The TTYH3 protein content of bile exosomes in patients with cholangiocarcinoma is increased, which promotes the invasion and metastasis of cholangiocarcinoma cells, while also promoting lymphangiogenesis and increased permeability. TTYH3 promotes the uptake of exosomes by lymphatic cells and promotes lymphangiogenesis by regulating the influx of calcium ions and chloride ions in lymphatic cells. Conclusions: TTYH3 promotes the invasion and metastasis of cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway, and exosome TTYH3 promotes lymphangiogenesis and lymph node metastasis.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Advanced Disease

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 57)

DOI

10.1200/JCO.2024.42.23_suppl.57

Abstract #

57

Poster Bd #

C9

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Molecular pathways involved in hepatoblastoma tumorigenesis in trisomy 18.

First Author: Emily Schepers

Abstract

2023 ASCO Gastrointestinal Cancers Symposium

The divergent role of the GM-CSF/GM-CSFR signaling pathway in cholangiocarcinoma and pancreatic ductal adenocarcinoma.

First Author: Yatee A. Dave

Abstract

2022 ASCO Annual Meeting

Characterization analysis of gut and bile microbiota for cholangiocarcinomas.

First Author: Wenwen Zhu